Validation of new COA for FSHD patients clinical trials

Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study

This study aims to develop better ways to measure how Facioscapulohumeral Muscular Dystrophy (FSHD) affects people over 24 months. It will help researchers test new treatments faster by finding reliable methods to track the disease and understand who might benefit most from future clinical trials.